comparemela.com
Home
Live Updates
Prnewswire Navrogen Inc - Breaking News
Pages:
Latest Breaking News On - Prnewswire navrogen inc - Page 1 : comparemela.com
Navrogen Presents Preclinical Data on NAV-001 Antibody-Drug Conjugate and NAV-003 Bispecific Programs at the 2023 American Association for Cancer Research Annual Meeting
/PRNewswire/ Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, will be presenting new.
United states
Steven kyriakos
Luigi grasso
Nicholas nicolaides
Navrogen incorporated
Prnewswire navrogen inc
American association for cancer research
Cancer research
Humoral immuno oncology
Chief scientific
Chief executive officer
vimarsana © 2020. All Rights Reserved.